Clinical Trials Browser

Phase 3 × Neurotoxicity Syndromes × neurotropin × Clear all

NCT07320950 2026-01-06

Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms, Neurotoxicity Syndromes